Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
International Journal of Bio-Medical Computing|June 1, 1994
Dosage regimen calculations with optimal control theoryA Iliadis, D BarbolosiComputers and Biomedical Research, an International Journal|June 22, 2000
Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical modelA Iliadis, D BarbolosiComputers in Biology and Medicine|February 15, 2001
Optimizing drug regimens in cancer chemotherapy: a simulation study using a PK-PD modelD Barbolosi, A IliadisCurrent Topics in Medicinal Chemistry|September 18, 2012
A new model for determining the MTD during phase-I trials in pediatric oncologyC Faivre, D Barbolosi, A IliadisJournal of Pharmacokinetics and Pharmacodynamics|December 25, 2008
An interface model for dosage adjustment connects hematotoxicity to pharmacokineticsC Meille, A Iliadis, D Barbolosi, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 10, 2002
Information tools for exploratory data analysis in population pharmacokineticsO Petricoul, L Claret, D Barbolosi, et al.Clinical Pharmacology and Therapeutics|October 25, 2007
New adaptive method for phase I trials in oncologyC Meille, J C Gentet, D Barbolosi, et al.Cancer Chemotherapy and Pharmacology|February 8, 2013
A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimensC Faivre, D Barbolosi, E Pasquier, et al.British Journal of Cancer|January 13, 2017
Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patientsC Faivre, R El Cheikh, D Barbolosi, et al.Mathematical Biosciences|April 1, 1996
Nonparametric density estimation applied to population pharmacokineticsL Claret, A IliadisPageof 9